LSL Pharma Group Inc. (TSXV:LSL)

LSL Pharma Group Revenue

LSL Pharma Group had revenue of 14.63M CAD in the quarter ending June 30, 2026, with 102.66% growth. This brings the company's total for the last twelve months to 41.83M, up 80.01% year-over-year. In the year 2025, LSL Pharma Group had annual revenue of 28.74M with 61.96% growth. That makes LSL Pharma Group the 31,356th largest company in the world by revenue and 562nd in Canada.

• Revenue (ttm): 41.83M
• Revenue Growth: +80.01%
• P/S Ratio: 0.91
• Revenue / Employee: 165.99K
• Employees: 252
• Market Cap: 39.92M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• CMO 25.50M 88.7%
• Eye-care Division 3.25M 11.3%

By Geography

Chart

• Canada 28.46M 99.0%
• Other Foreign Markets 160.00K 0.6%
• United States 124.00K 0.4%

Fiscal year ended Dec 31, 2025 See the full LSL Pharma Group breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	28.74M	11.00M	61.96%
Dec 31, 2024	17.75M	7.72M	76.98%
Dec 31, 2023	10.03M	1.81M	22.08%
Dec 31, 2022	8.21M	-557.15K	-6.35%
Dec 31, 2021	8.77M	-1.28M	-12.70%

Data Source: S&P Global Market Intelligence Last updated: Aug 24, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error